How would you follow a patient with polycythemia without secondary causes on evaluation who was found to have a normal erythropoietin level and JAK2 V617F mutation but VAF < 2%?
If bone marrow biopsy only showed erythroid hyperplasia, would that sufficiently exclude PV? Would you trend JAK2 V617F VAFs over time?